What is Onto Innovation's operating income?

Onto Innovation's total operating income in 2024 was $132.93 million, based on the following breakdown: Total Gross Profit: $499.77 million Total Operating Expenses: $366.84 million

Onto Innovation (ONTO) Financials

$293.68 -5.16 (-1.73%)

As of 08/21/2026 03:58 PM Eastern

Compare

Annual Income Statements for Onto Innovation

This table shows Onto Innovation's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/27/2014	12/26/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/26/2020	1/1/2022	12/31/2022	12/30/2023	1/3/2026
Net Income / (Loss) Attributable to Common Shareholders	-31	2.91	44	33	45	1.91	31	142	223	121	137
Consolidated Net Income / (Loss)	-31	2.91	44	33	45	1.91	31	142	223	121	137
Net Income / (Loss) Continuing Operations	-31	2.91	44	33	45	1.91	31	142	223	121	137
Total Pre-Tax Income	-12	5.57	29	60	53	-0.60	-27	156	242	133	163
Total Operating Income	-12	4.97	29	59	51	-5.04	-27	156	237	116	133
Total Gross Profit	76	90	114	135	148	135	278	429	539	420	500
Total Revenue	166	187	221	255	274	306	556	789	1,005	816	1,005
Operating Revenue	166	187	221	255	274	306	556	789	1,005	816	1,005
Total Cost of Revenue	91	98	107	121	126	171	278	360	466	396	505
Operating Cost of Revenue	91	98	107	121	126	171	278	360	466	396	505
Total Operating Expenses	87	85	85	75	97	140	252	273	303	304	367
Selling, General & Admin Expense	24	22	23	28	34	53	65	68	70	80	107
Marketing Expense	27	28	30	21	22	28	48	57	66	62	70
Research & Development Expense	34	33	31	38	40	48	85	96	112	104	132
Amortization Expense	0.42	0.11	0.02	1.94	1.53	10	54	51	55	55	39
Other Operating Expenses / (Income)	-	-	-	-	-	-	-	-	-	3.57	18
Total Other Income / (Expense), net	0.03	0.60	0.04	0.51	2.26	4.45	0.19	-0.73	4.87	17	30
Interest & Investment Income	0.05	0.07	0.04	0.97	2.21	3.67	2.90	1.16	5.01	20	35
Other Income / (Expense), net	0.37	0.81	0.29	-0.46	0.06	0.78	-2.71	-1.89	-0.14	-3.85	-5.00
Income Tax Expense	19	2.66	-15	27	8.25	-2.51	-4.16	13	18	11	26
Basic Earnings per Share	($1.30)	$0.12	$1.79	$1.30	$1.77	$0.06	$0.63	$2.89	$4.52	$2.47	$2.78
Weighted Average Basic Shares Outstanding	23.96M	24.06M	24.66M	25.33M	25.47M	29.73M	49.14M	49.24M	49.42M	48.97M	49.12M
Diluted Earnings per Share	($1.30)	$0.12	$1.75	$1.27	$1.74	$0.06	$0.63	$2.86	$4.49	$2.46	$2.78
Weighted Average Diluted Shares Outstanding	23.96M	24.38M	25.15M	25.87M	25.90M	30.01M	49.48M	49.73M	49.76M	49.32M	49.27M
Weighted Average Basic & Diluted Shares Outstanding	23.90M	24.20M	24.60M	25.40M	24.10M	50.28M	48.88M	49.36M	48.75M	49.13M	49.70M

This table shows Onto Innovation's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026
Period end date	9/30/2023	12/30/2023	3/30/2024	6/29/2024	9/28/2024	12/28/2024	3/29/2025	6/28/2025	9/27/2025	3/31/2026	6/30/2026
Net Income / (Loss) Attributable to Common Shareholders	36	30	47	53	53	49	64	34	28	34	60
Consolidated Net Income / (Loss)	36	30	47	53	53	49	64	34	28	34	60
Net Income / (Loss) Continuing Operations	36	30	47	53	53	49	64	34	28	34	60
Total Pre-Tax Income	39	34	51	57	61	51	72	40	32	38	68
Total Operating Income	34	28	43	49	53	42	63	32	24	34	64
Total Gross Profit	107	108	118	128	136	132	143	122	111	146	183
Total Revenue	207	219	229	242	252	264	267	254	218	292	343
Operating Revenue	207	219	229	242	252	264	267	254	218	292	343
Total Cost of Revenue	100	111	111	114	118	132	123	138	112	151	164
Operating Cost of Revenue	100	111	111	114	118	132	123	138	112	151	164
Total Operating Expenses	73	80	76	79	81	90	80	84	83	108	116
Selling, General & Admin Expense	18	27	18	20	20	26	23	25	25	31	34
Marketing Expense	15	15	18	19	19	19	20	15	17	21	23
Research & Development Expense	26	24	27	27	28	35	28	35	32	35	39
Amortization Expense	14	13	13	13	13	10	8.45	8.45	8.45	20	20
Total Other Income / (Expense), net	4.69	5.60	8.15	8.44	7.94	8.81	8.52	7.49	8.29	4.54	4.95
Interest & Investment Income	5.69	6.46	7.36	8.50	8.67	8.97	9.27	8.63	9.29	5.10	5.25
Other Income / (Expense), net	-1.00	-0.86	0.79	-0.06	-0.72	-0.15	-0.74	-1.14	-1.00	-0.56	-0.30
Income Tax Expense	2.81	3.52	4.04	4.32	7.96	2.45	7.56	5.83	3.76	4.30	8.39
Basic Earnings per Share	$0.73	$0.61	$0.95	$1.07	$1.07	$1.00	$1.30	$0.69	$0.58	$0.68	$1.22
Weighted Average Basic Shares Outstanding	49.04M	48.97M	49.23M	49.34M	49.43M	49.34M	49.18M	48.93M	49.02M	49.74M	49.41M
Diluted Earnings per Share	$0.73	$0.61	$0.94	$1.07	$1.07	$0.98	$1.30	$0.69	$0.57	$0.67	$1.21
Weighted Average Diluted Shares Outstanding	49.40M	49.32M	49.64M	49.67M	49.69M	49.66M	49.41M	49.02M	49.11M	50.00M	49.68M
Weighted Average Basic & Diluted Shares Outstanding	49.08M	49.13M	49.28M	49.38M	49.39M	49.27M	48.87M	49.00M	49.01M	49.74M	49.07M

This table details how cash moves in and out of Onto Innovation's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/27/2014	12/26/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/26/2020	1/1/2022	12/31/2022	12/30/2023	1/3/2026
Net Change in Cash & Equivalents	-10	3.48	8.91	30	45	18	-52	33	24	58	133
Net Cash From Operating Activities	-0.64	1.57	46	64	35	18	106	175	137	172	328
Net Cash From Continuing Operating Activities	-0.64	1.57	46	64	35	18	50	175	148	172	328
Net Income / (Loss) Continuing Operations	-31	2.91	44	33	45	1.91	31	142	223	121	137
Consolidated Net Income / (Loss)	-31	2.91	44	33	45	1.91	31	142	223	121	137
Depreciation Expense	9.77	9.08	8.30	3.99	4.85	5.97	14	14	9.38	12	21
Amortization Expense	-	-	-	1.94	1.53	26	64	52	55	50	35
Non-Cash Adjustments To Reconcile Net Income	15	9.02	11	9.87	11	24	37	30	40	39	63
Changes in Operating Assets and Liabilities, net	5.63	-19	-17	15	-27	-39	-97	-63	-180	-50	73
Net Cash From Investing Activities	-8.05	1.95	-42	-33	34	4.10	49	-142	-56	-103	-122
Net Cash From Continuing Investing Activities	-8.05	1.95	-42	-33	34	4.10	-49	-142	-56	-103	-122
Purchase of Property, Plant & Equipment	-5.79	-1.85	-4.00	-10	-7.54	-6.80	-3.83	-12	-18	-23	-29
Acquisitions	-	-	0.00	-1.00	-	0.00	0.00	-24	-4.64	0.00	-436
Purchase of Investments	-41	-41	-83	-165	-140	-127	-313	-361	-371	-480	-476
Sale of Property, Plant & Equipment	-	-	0.00	-	-	-	-	0.00	0.00	2.80	0.00
Sale and/or Maturity of Investments	39	45	45	143	186	94	265	255	339	397	827
Other Investing Activities, net	-	-	-	0.00	-5.00	0.00	2.85	-	-	0.00	-8.00
Net Cash From Financing Activities	-0.68	0.22	5.27	-2.55	-24	-4.20	-54	2.67	-68	-9.48	-75
Net Cash From Continuing Financing Activities	-0.68	0.22	5.27	-2.55	-24	-4.20	-54	2.67	-68	-9.48	-75
Repurchase of Common Equity	-5.34	-1.72	0.00	-1.03	-21	-0.74	-52	0.00	-65	-3.20	-75
Issuance of Common Equity	5.96	3.97	8.45	0.62	0.62	0.84	2.92	10	8.07	5.29	13
Other Financing Activities, net	-0.70	-1.18	-2.86	-2.15	-3.46	-4.30	-4.62	-7.40	-11	-12	-14
Effect of Exchange Rate Changes	-0.73	-0.26	0.08	0.81	-0.34	0.23	-	-	-	-1.48	1.58
Cash Income Taxes Paid	0.86	-0.83	3.77	15	4.30	-3.85	0.00	24	59	34	36

This table details how cash moves in and out of Onto Innovation's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026
Period end date	9/30/2023	12/30/2023	3/30/2024	6/29/2024	9/28/2024	12/28/2024	3/29/2025	6/28/2025	9/27/2025	3/31/2026	6/30/2026
Net Change in Cash & Equivalents	-18	51	-43	-18	16	24	-9.22	14	386	-94	1,247
Net Cash From Operating Activities	29	62	57	65	67	56	92	58	83	26	62
Net Cash From Continuing Operating Activities	29	84	57	65	67	56	92	58	83	26	218
Net Income / (Loss) Continuing Operations	36	30	47	53	53	49	64	34	28	34	60
Consolidated Net Income / (Loss)	36	30	47	53	53	49	64	34	28	34	60
Depreciation Expense	3.20	3.37	3.39	3.53	3.90	2.05	4.40	5.84	4.94	5.78	5.83
Amortization Expense	14	13	12	13	13	10	6.91	6.95	7.18	19	21
Non-Cash Adjustments To Reconcile Net Income	7.64	9.49	7.99	9.85	9.81	25	9.52	27	9.10	8.88	11
Changes in Operating Assets and Liabilities, net	-32	28	-13	-14	-13	-30	7.06	-16	34	-42	119
Net Cash From Investing Activities	-43	-37	-92	-74	-57	-4.10	-22	-43	297	-113	-230
Net Cash From Continuing Investing Activities	-43	-37	-92	-74	-57	-4.10	-22	-43	297	-113	-230
Purchase of Property, Plant & Equipment	-7.65	-2.46	-6.98	-12	-8.05	-4.63	-8.23	-14	-1.38	-3.59	-3.66
Purchase of Investments	-151	-120	-208	-187	-143	-171	-209	-211	-1.84	-180	-473
Sale and/or Maturity of Investments	115	83	123	125	95	198	203	182	300	70	246
Net Cash From Financing Activities	-0.92	-0.39	-5.07	-8.87	3.95	-26	-80	-3.71	5.36	-6.70	1,170
Net Cash From Continuing Financing Activities	-0.92	-0.39	-5.07	-8.87	3.95	-26	-80	-3.71	5.36	-6.70	1,259
Repurchase of Common Equity	-	-	0.00	-	-	-25	-75	-	-	0.00	-205
Issuance of Common Equity	-	-	4.02	-0.00	5.16	-	4.18	-	5.56	0.00	5.93
Other Financing Activities, net	-0.92	-0.39	-9.09	-8.87	-1.22	-0.60	-8.68	-3.71	-0.20	-6.70	-12
Cash Income Taxes Paid	10	5.17	0.92	21	8.71	5.27	0.77	32	2.83	1.57	3.55

This table presents Onto Innovation's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/26/2015	12/31/2016	12/30/2017	12/31/2018	12/31/2019	12/26/2020	1/1/2022	12/31/2022	12/30/2023	12/28/2024	1/3/2026
Total Assets	236	288	310	418	1,449	1,468	1,650	1,795	1,910	2,117	2,368
Total Current Assets	178	216	240	351	642	732	948	1,135	1,283	1,478	1,268
Cash & Equivalents	38	47	35	112	131	137	170	176	234	213	346
Short-Term Investments	45	83	82	63	190	237	342	372	464	639	294
Accounts Receivable	38	39	62	64	124	149	177	241	227	308	269
Inventories, net	51	41	54	97	176	191	243	324	328	287	298
Prepaid Expenses	6.59	5.67	6.23	15	22	17	16	21	31	30	61
Plant, Property, & Equipment, net	44	44	45	19	98	88	82	92	104	124	127
Total Noncurrent Assets	13	27	25	48	708	649	620	568	523	516	973
Goodwill	9.42	8.94	10	22	307	307	316	316	316	330	644
Intangible Assets	1.87	0.41	2.21	7.45	372	318	277	222	167	127	298
Noncurrent Deferred & Refundable Income Taxes	1.12	17	12	13	1.46	2.24	4.82	4.78	19	43	3.86
Other Noncurrent Operating Assets	0.53	0.47	0.41	5.51	28	21	22	25	21	15	27
Total Liabilities & Shareholders' Equity	236	288	310	418	1,449	1,468	1,650	1,795	1,910	2,117	2,368
Total Liabilities	48	44	47	56	185	203	224	198	173	191	267
Total Current Liabilities	45	42	44	45	86	120	155	161	148	170	219
Accounts Payable	12	11	14	17	28	40	53	55	50	56	108
Accrued Expenses	-	-	-	14	26	37	43	49	42	50	49
Current Deferred Revenue	13	9.17	7.41	6.77	13	14	30	30	25	34	32
Other Current Liabilities	8.88	8.05	7.25	7.54	19	28	28	27	31	30	31
Total Noncurrent Liabilities	3.00	2.03	3.22	11	99	83	69	38	25	21	48
Long-Term Debt	-	-	-	-	-	-	-	-	-	-	0.00
Noncurrent Deferred & Payable Income Tax Liabilities	0.52	0.02	0.18	0.00	67	56	40	7.37	0.00	0.00	20
Other Noncurrent Operating Liabilities	0.88	0.35	0.52	11	32	28	29	31	25	21	28
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	187	244	262	362	1,264	1,265	1,426	1,596	1,737	1,926	2,101
Total Preferred & Common Equity	187	244	262	362	1,264	1,265	1,426	1,596	1,737	1,926	2,101
Total Common Equity	187	244	262	362	1,264	1,265	1,426	1,596	1,737	1,926	2,101
Common Stock	259	272	255	370	1,269	1,234	1,256	1,244	1,262	1,275	1,367
Retained Earnings	-66	-22	9.11	-6.77	-4.86	26	169	363	482	665	744
Accumulated Other Comprehensive Income / (Loss)	-5.20	-6.05	-2.12	-1.26	-0.60	4.57	1.32	-10	-7.90	-14	-10

This table presents Onto Innovation's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026
Period end date	4/1/2023	7/1/2023	9/30/2023	3/30/2024	6/29/2024	9/28/2024	3/29/2025	6/28/2025	9/27/2025	3/31/2026	6/30/2026
Total Assets	1,803	1,821	1,862	1,953	2,005	2,073	2,115	2,140	2,187	2,396	3,699
Total Current Assets	1,155	1,183	1,221	1,333	1,385	1,458	1,469	1,494	1,545	1,320	2,642
Cash & Equivalents	230	224	207	191	173	189	204	217	603	252	1,253
Short-Term Investments	353	385	423	550	613	667	647	677	381	402	629
Accounts Receivable	210	188	210	232	238	254	292	285	260	307	337
Inventories, net	338	352	346	330	320	308	293	270	259	316	379
Prepaid Expenses	24	34	36	31	42	41	34	44	41	43	43
Plant, Property, & Equipment, net	98	100	104	107	115	120	127	133	129	124	124
Total Noncurrent Assets	550	538	537	514	505	495	519	513	513	953	933
Goodwill	316	316	316	316	316	316	330	330	330	643	643
Intangible Assets	208	195	181	154	141	128	119	111	102	278	259
Noncurrent Deferred & Refundable Income Taxes	4.79	8.32	18	24	29	35	47	50	57	4.45	4.41
Other Noncurrent Operating Assets	21	19	22	19	18	17	23	22	23	27	27
Total Liabilities & Shareholders' Equity	1,803	1,821	1,862	1,953	2,005	2,073	2,115	2,140	2,187	2,396	3,699
Total Liabilities	178	164	166	172	174	170	195	177	185	264	1,776
Total Current Liabilities	148	137	136	147	148	145	174	156	163	214	272
Accounts Payable	54	50	44	56	51	48	55	38	53	106	139
Accrued Expenses	38	36	39	35	40	44	42	50	49	46	55
Current Deferred Revenue	28	24	23	26	28	27	39	39	31	31	36
Other Current Liabilities	29	27	29	30	28	26	38	29	30	31	41
Total Noncurrent Liabilities	30	27	30	25	25	25	21	21	22	50	1,505
Long-Term Debt	-	-	-	-	-	-	-	-	-	-	1,472
Noncurrent Deferred & Payable Income Tax Liabilities	1.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	20	2.10
Other Noncurrent Operating Liabilities	28	27	30	25	25	25	21	21	22	29	31
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,625	1,657	1,696	1,782	1,832	1,904	1,920	1,963	2,002	2,132	1,923
Total Preferred & Common Equity	1,625	1,657	1,696	1,782	1,832	1,904	1,920	1,963	2,002	2,132	1,923
Total Common Equity	1,625	1,657	1,696	1,782	1,832	1,904	1,920	1,963	2,002	2,132	1,923
Common Stock	1,242	1,251	1,257	1,263	1,263	1,275	1,260	1,263	1,275	1,367	1,098
Retained Earnings	390	416	452	529	582	635	671	705	733	778	838
Accumulated Other Comprehensive Income / (Loss)	-7.53	-11	-13	-11	-13	-6.33	-12	-4.75	-6.42	-13	-13

This table displays calculated financial ratios and metrics derived from Onto Innovation's official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/27/2014	12/26/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/26/2020	1/1/2022	12/31/2022	12/30/2023	12/28/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	15.34%	12.57%	18.02%	15.36%	7.33%	11.73%	81.92%	41.76%	27.42%	-18.83%	21.01%
EBITDA Growth	89.34%	1,082.87%	153.55%	71.87%	-11.18%	-52.16%	77.60%	351.62%	36.48%	-40.43%	38.92%
EBIT Growth	50.91%	151.30%	407.86%	100.21%	-13.07%	-108.34%	-589.30%	625.84%	53.10%	-52.56%	66.59%
NOPAT Growth	46.32%	131.81%	1,594.87%	-25.81%	32.36%	-108.17%	-428.99%	865.84%	53.02%	-51.53%	61.36%
Net Income Growth	-119.98%	109.34%	1,415.83%	-25.27%	37.03%	-95.76%	1,524.35%	358.82%	56.89%	-45.75%	66.45%
EPS Growth	-113.11%	109.23%	1,358.33%	-27.43%	37.01%	-96.55%	950.00%	353.97%	56.99%	-45.21%	65.04%
Operating Cash Flow Growth	73.88%	347.40%	2,808.02%	40.46%	-45.31%	-48.29%	484.06%	65.38%	-22.01%	25.80%	42.86%
Free Cash Flow Firm Growth	158.13%	-156.35%	666.48%	-96.85%	58.67%	-44,268.62%	104.48%	250.00%	-28.85%	36.62%	17.54%
Invested Capital Growth	-16.54%	9.07%	9.18%	27.71%	28.52%	405.20%	-5.59%	2.66%	14.64%	-0.95%	3.35%
Revenue Q/Q Growth	-3.73%	1.62%	8.05%	6.48%	-15.02%	44.55%	6.62%	9.82%	2.83%	-4.05%	4.78%
EBITDA Q/Q Growth	-136.60%	33.37%	34.99%	60.93%	-39.27%	57.65%	-34.65%	67.74%	4.26%	-16.41%	4.34%
EBIT Q/Q Growth	-66.36%	80.25%	52.85%	77.38%	-43.79%	-130.08%	-117.36%	136.12%	5.96%	-24.15%	8.68%
NOPAT Q/Q Growth	-77.77%	4,256.71%	180.41%	-28.13%	-26.55%	-125.82%	-134.15%	126.37%	7.69%	-25.55%	9.74%
Net Income Q/Q Growth	-20.04%	3,577.22%	182.86%	-28.55%	-23.73%	-90.02%	567.17%	23.22%	9.55%	-22.86%	10.10%
EPS Q/Q Growth	-21.50%	0.00%	186.89%	-29.83%	-26.89%	-90.91%	226.00%	22.22%	10.05%	-22.88%	10.03%
Operating Cash Flow Q/Q Growth	92.13%	-86.05%	37.09%	137.95%	-73.45%	177.50%	60.33%	9.96%	0.36%	7.56%	-2.22%
Free Cash Flow Firm Q/Q Growth	1,321.08%	-347.74%	65.86%	-88.43%	-97.60%	-1,087.42%	104.83%	146.24%	-13.84%	25.17%	-21.80%
Invested Capital Q/Q Growth	-9.46%	1.04%	16.00%	8.37%	54.22%	374.61%	-0.70%	0.30%	3.15%	-2.60%	2.43%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	45.55%	47.86%	51.61%	52.76%	54.16%	44.14%	50.04%	54.39%	53.64%	51.51%	52.19%
EBITDA Margin	-0.91%	7.93%	17.04%	25.39%	21.01%	9.00%	8.78%	27.98%	29.97%	21.99%	25.25%
Operating Margin	-7.00%	2.65%	13.16%	23.24%	18.66%	-1.65%	-4.79%	19.83%	23.55%	14.23%	18.95%
EBIT Margin	-6.78%	3.09%	13.29%	23.06%	18.68%	-1.39%	-5.28%	19.59%	23.54%	13.76%	18.94%
Profit (Net Income) Margin	-18.70%	1.55%	19.91%	12.90%	16.47%	0.62%	5.58%	18.04%	22.22%	14.85%	20.43%
Tax Burden Percent	267.77%	52.17%	151.14%	55.03%	84.53%	-319.93%	-115.47%	91.44%	92.45%	91.38%	91.48%
Interest Burden Percent	103.03%	96.23%	99.15%	101.65%	104.31%	14.00%	91.43%	100.75%	102.12%	118.14%	117.91%
Effective Tax Rate	0.00%	47.83%	-51.14%	44.97%	15.47%	0.00%	0.00%	8.56%	7.55%	8.62%	8.52%
Return on Invested Capital (ROIC)	-7.77%	2.60%	40.33%	25.18%	26.00%	-0.62%	-2.04%	15.84%	22.29%	10.16%	16.21%
ROIC Less NNEP Spread (ROIC-NNEP)	18.20%	2.23%	40.28%	24.95%	24.69%	-2.82%	-16.36%	15.99%	21.44%	7.74%	12.27%
Return on Net Nonoperating Assets (RNNOA)	-8.32%	-1.01%	-19.90%	-12.17%	-11.55%	0.86%	4.49%	-5.26%	-7.51%	-2.89%	-5.19%
Return on Equity (ROE)	-16.09%	1.58%	20.43%	13.00%	14.45%	0.23%	2.45%	10.58%	14.78%	7.27%	11.01%
Cash Return on Invested Capital (CROIC)	10.26%	-6.08%	31.56%	0.84%	1.04%	-134.53%	3.72%	13.22%	8.65%	11.11%	12.91%
Operating Return on Assets (OROA)	-4.64%	2.52%	11.23%	19.69%	14.05%	-0.46%	-2.01%	9.91%	13.74%	6.06%	9.29%
Return on Assets (ROA)	-12.80%	1.27%	16.83%	11.02%	12.39%	0.20%	2.13%	9.13%	12.97%	6.54%	10.02%
Return on Common Equity (ROCE)	-16.09%	1.58%	20.43%	13.00%	14.45%	0.23%	2.45%	10.58%	14.78%	7.27%	11.01%
Return on Equity Simple (ROE_SIMPLE)	-17.33%	1.55%	18.06%	12.54%	12.46%	0.15%	2.45%	9.98%	13.99%	6.98%	10.47%
Net Operating Profit after Tax (NOPAT)	-8.16	2.59	44	33	43	-3.53	-19	143	219	106	171
NOPAT Margin	-4.90%	1.38%	19.89%	12.79%	15.77%	-1.15%	-3.36%	18.13%	21.77%	13.00%	17.34%
Net Nonoperating Expense Percent (NNEP)	-25.97%	0.37%	0.06%	0.23%	1.31%	2.20%	14.32%	-0.15%	0.85%	2.42%	3.94%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	13.71%	6.11%	8.89%
Cost of Revenue to Revenue	54.45%	52.14%	48.39%	47.24%	45.84%	55.86%	49.96%	45.61%	46.36%	48.49%	47.81%
SG&A Expenses to Revenue	14.41%	11.98%	10.57%	10.93%	12.31%	17.33%	11.74%	8.61%	6.92%	10.19%	8.69%
R&D to Revenue	20.29%	17.45%	14.22%	14.78%	14.59%	15.81%	15.20%	12.18%	11.14%	12.80%	11.83%
Operating Expenses to Revenue	52.56%	45.20%	38.45%	29.52%	35.50%	45.79%	45.24%	34.56%	30.09%	37.28%	33.24%
Earnings before Interest and Taxes (EBIT)	-11	5.79	29	59	51	-4.26	-29	155	237	112	187
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-1.51	15	38	65	58	28	49	221	301	179	249
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.23	2.04	2.56	2.43	1.83	1.45	1.85	3.50	2.11	4.32	4.38
Price to Tangible Book Value (P/TBV)	2.43	2.17	2.66	2.55	1.99	3.13	3.67	5.99	3.19	5.99	5.74
Price to Revenue (P/Rev)	2.41	2.04	2.82	2.50	2.42	5.98	4.21	6.32	3.35	9.20	8.54
Price to Earnings (P/E)	0.00	131.47	14.18	19.38	14.68	957.73	75.58	35.04	15.10	61.94	41.80
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.76%	7.05%	5.16%	6.81%	0.10%	1.32%	2.85%	6.62%	1.61%	2.39%
Enterprise Value to Invested Capital (EV/IC)	3.31	2.87	4.34	3.58	2.61	1.60	2.21	4.89	2.69	6.55	7.06
Enterprise Value to Revenue (EV/Rev)	1.90	1.60	2.24	2.04	1.78	4.93	3.54	5.68	2.81	8.34	7.67
Enterprise Value to EBITDA (EV/EBITDA)	0.00	20.11	13.12	8.04	8.46	54.84	40.33	20.28	9.37	37.93	30.40
Enterprise Value to EBIT (EV/EBIT)	0.00	51.65	16.83	8.85	9.52	0.00	0.00	28.97	11.94	60.65	40.53
Enterprise Value to NOPAT (EV/NOPAT)	0.00	115.18	11.24	15.96	11.27	0.00	0.00	31.31	12.90	64.17	44.27
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	190.23	10.82	8.12	13.87	83.16	18.60	25.54	20.66	39.58	30.84
Enterprise Value to Free Cash Flow (EV/FCFF)	29.39	0.00	14.37	479.93	282.69	0.00	57.82	37.52	33.26	58.68	55.57
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.46	-0.46	-0.49	-0.49	-0.47	-0.30	-0.27	-0.33	-0.35	-0.37	-0.42
Leverage Ratio	1.26	1.25	1.21	1.18	1.17	1.15	1.15	1.16	1.14	1.11	1.10
Compound Leverage Factor	1.29	1.20	1.20	1.20	1.22	0.16	1.05	1.17	1.16	1.31	1.30
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	6.29	5.91	10.23	10.34	8.99	6.60	7.75	14.88	12.12	27.69	28.39
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.13	3.94	5.15	5.45	7.80	7.48	6.09	6.14	7.07	8.69	8.69
Quick Ratio	2.88	2.67	4.03	4.07	5.32	5.18	4.35	4.46	4.92	6.26	6.82
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	11	-6.07	34	1.09	1.72	-761	34	119	85	116	136
Operating Cash Flow to CapEx	-10.96%	85.10%	1,142.41%	628.51%	465.31%	266.77%	2,767.93%	1,455.94%	742.75%	869.74%	770.07%
Free Cash Flow to Firm to Interest Expense	27.71	-21.02	120.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	-1.63	5.44	160.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	-16.52	-0.95	146.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.68	0.82	0.85	0.85	0.75	0.33	0.38	0.51	0.58	0.44	0.49
Accounts Receivable Turnover	5.78	5.86	5.72	5.01	4.32	3.26	4.08	4.83	4.80	3.49	3.69
Inventory Turnover	2.31	2.23	2.33	2.52	1.66	1.25	1.51	1.66	1.64	1.21	1.54
Fixed Asset Turnover	3.43	3.98	4.98	5.73	8.60	5.22	5.97	9.28	11.55	8.34	8.68
Accounts Payable Turnover	8.71	8.93	9.30	9.56	8.14	7.64	8.19	7.69	8.64	7.58	8.90
Days Sales Outstanding (DSO)	63.11	62.29	63.79	72.91	84.42	112.07	89.50	75.52	76.00	104.68	98.84
Days Inventory Outstanding (DIO)	157.96	163.67	156.74	144.92	219.88	291.54	241.12	220.29	222.23	300.80	237.69
Days Payable Outstanding (DPO)	41.89	40.86	39.26	38.16	44.84	47.76	44.58	47.44	42.25	48.16	41.03
Cash Conversion Cycle (CCC)	179.18	185.11	181.27	179.67	259.47	355.85	286.04	248.38	255.98	357.32	295.49
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	96	104	114	145	187	944	891	915	1,049	1,039	1,074
Invested Capital Turnover	1.58	1.88	2.03	1.97	1.65	0.54	0.61	0.87	1.02	0.78	0.93
Increase / (Decrease) in Invested Capital	-19	8.67	9.57	32	41	757	-53	24	134	-9.92	35
Enterprise Value (EV)	317	299	494	521	487	1,509	1,971	4,477	2,824	6,807	7,577
Market Capitalization	401	382	624	638	662	1,829	2,345	4,988	3,372	7,504	8,429
Book Value per Share	$7.43	$7.74	$9.78	$10.25	$14.94	$25.25	$25.90	$28.94	$32.24	$35.38	$38.99
Tangible Book Value per Share	$6.82	$7.28	$9.41	$9.77	$13.71	$11.68	$13.10	$16.90	$21.37	$25.54	$29.73
Total Capital	180	187	244	262	362	1,264	1,265	1,426	1,596	1,737	1,926
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-84	-83	-130	-117	-175	-320	-374	-511	-548	-698	-852
Capital Expenditures (CapEx)	5.79	1.85	4.00	10	7.54	6.80	3.83	12	18	20	32
Debt-free, Cash-free Net Working Capital (DFCFNWC)	36	50	44	79	131	236	238	282	427	438	455
Debt-free Net Working Capital (DFNWC)	120	133	174	196	306	556	612	794	974	1,136	1,307
Net Working Capital (NWC)	120	133	174	196	306	556	612	794	974	1,136	1,307
Net Nonoperating Expense (NNE)	23	-0.31	-0.06	-0.28	-1.91	-5.44	-50	0.66	-4.50	-15	-31
Net Nonoperating Obligations (NNO)	-84	-83	-130	-117	-175	-320	-374	-511	-548	-698	-852
Total Depreciation and Amortization (D&A)	9.77	9.08	8.30	5.93	6.38	32	78	66	65	67	62
Debt-free, Cash-free Net Working Capital to Revenue	21.44%	26.59%	20.08%	30.96%	47.79%	77.05%	42.74%	35.77%	42.43%	53.65%	46.09%
Debt-free Net Working Capital to Revenue	71.88%	70.93%	78.85%	76.84%	111.74%	181.74%	109.90%	100.59%	96.93%	139.18%	132.42%
Net Working Capital to Revenue	71.88%	70.93%	78.85%	76.84%	111.74%	181.74%	109.90%	100.59%	96.93%	139.18%	132.42%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($1.30)	$0.12	$1.79	$1.19	$2.39	$0.06	$0.63	$2.89	$0.00	$2.47	$4.09
Adjusted Weighted Average Basic Shares Outstanding	23.96M	24.06M	24.66M	25.33M	24.12M	29.73M	49.14M	49.24M	0.00	48.97M	49.34M
Adjusted Diluted Earnings per Share	($1.30)	$0.12	$1.75	$1.17	$2.34	$0.06	$0.63	$2.86	$0.00	$2.46	$4.06
Adjusted Weighted Average Diluted Shares Outstanding	23.96M	24.38M	25.15M	25.92M	24.60M	30.01M	49.48M	49.73M	0.00	49.32M	49.66M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	23.85M	24.30M	25.16M	23.76M	24.46M	50.28M	48.88M	49.36M	0.00	49.13M	49.27M
Normalized Net Operating Profit after Tax (NOPAT)	-6.57	3.31	20	25	43	-3.53	-19	143	219	106	171
Normalized NOPAT Margin	-3.95%	1.77%	9.21%	9.99%	15.77%	-1.15%	-3.36%	18.13%	21.77%	13.00%	17.34%
Pre Tax Income Margin	-6.98%	2.97%	13.18%	23.44%	19.48%	-0.20%	-4.83%	19.73%	24.03%	16.25%	22.33%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-28.99	20.02	103.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	-20.97	8.98	154.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	-43.88	13.63	89.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	-35.86	2.59	140.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-1.89%	29.29%	0.72%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-19.06%	88.54%	0.72%	3.11%	46.72%	38.95%	167.61%	0.00%	29.22%	2.64%	12.43%

This table displays calculated financial ratios and metrics derived from Onto Innovation's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026
Period end date	9/30/2023	12/30/2023	3/30/2024	6/29/2024	9/28/2024	12/28/2024	3/29/2025	6/28/2025	9/27/2025	3/31/2026	6/30/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	49,702,361.00	49,743,567.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	49,702,361.00	49,743,567.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	0.68	1.21
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-18.51%	-13.59%	14.90%	27.10%	21.73%	20.60%	16.50%	4.65%	-13.49%	9.51%	35.30%
EBITDA Growth	-32.83%	-44.41%	31.95%	64.28%	38.63%	23.52%	26.09%	-30.94%	-48.38%	-21.02%	80.55%
EBIT Growth	-43.43%	-56.62%	51.39%	111.17%	58.61%	54.57%	43.33%	-36.21%	-56.66%	-47.19%	103.31%
NOPAT Growth	-39.04%	-59.09%	50.12%	95.77%	46.33%	59.83%	43.52%	-39.05%	-54.69%	-47.36%	102.65%
Net Income Growth	-31.27%	-54.23%	61.18%	104.47%	47.83%	61.06%	36.80%	-35.96%	-46.80%	-47.34%	77.23%
EPS Growth	-30.48%	-54.48%	59.32%	101.89%	46.58%	60.66%	38.30%	-35.51%	-46.73%	-48.46%	75.36%
Operating Cash Flow Growth	-10.02%	24.43%	14.11%	106.07%	134.87%	-9.07%	61.00%	-11.27%	24.01%	-71.38%	6.15%
Free Cash Flow Firm Growth	65.46%	148.84%	147.15%	213.41%	452.82%	-84.10%	-29.50%	-89.64%	-21.10%	-1,450.72%	-8,135.55%
Invested Capital Growth	4.90%	-0.95%	-0.05%	-0.14%	-1.72%	3.35%	2.73%	2.17%	-2.86%	38.26%	41.55%
Revenue Q/Q Growth	8.67%	5.63%	4.56%	5.89%	4.08%	4.65%	1.01%	-4.88%	-13.96%	0.00%	17.53%
EBITDA Q/Q Growth	25.64%	-11.87%	36.15%	8.97%	6.02%	-21.48%	35.32%	-40.42%	-20.72%	0.00%	55.00%
EBIT Q/Q Growth	42.90%	-17.07%	59.05%	12.04%	7.33%	-19.18%	47.48%	-50.14%	-27.07%	0.00%	91.96%
NOPAT Q/Q Growth	36.73%	-19.79%	55.55%	14.75%	2.20%	-12.39%	39.68%	-51.27%	-24.02%	0.00%	87.59%
Net Income Q/Q Growth	38.58%	-15.54%	54.58%	13.01%	0.19%	-7.98%	31.30%	-47.09%	-16.77%	0.00%	78.08%
EPS Q/Q Growth	37.74%	-16.44%	54.10%	13.83%	0.00%	-8.41%	32.65%	-46.92%	-17.39%	0.00%	80.60%
Operating Cash Flow Q/Q Growth	-9.64%	115.10%	-7.23%	14.30%	2.98%	-16.73%	64.25%	-37.00%	43.93%	0.00%	133.67%
Free Cash Flow Firm Q/Q Growth	55.52%	292.61%	13.12%	17.03%	38.37%	-91.32%	401.64%	-82.80%	953.53%	0.00%	-2.34%
Invested Capital Q/Q Growth	1.85%	-2.60%	0.18%	0.48%	0.24%	2.43%	-0.42%	-0.06%	-4.70%	0.00%	2.31%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	51.57%	49.33%	51.69%	52.92%	54.07%	50.17%	53.72%	48.16%	50.70%	50.14%	53.41%
EBITDA Margin	24.15%	20.15%	26.23%	27.00%	27.50%	20.63%	27.64%	17.31%	15.95%	19.94%	26.29%
Operating Margin	16.41%	12.90%	18.68%	20.15%	21.04%	16.09%	23.68%	12.72%	10.86%	11.48%	18.52%
EBIT Margin	15.93%	12.51%	19.02%	20.13%	20.76%	16.03%	23.40%	12.27%	10.40%	11.29%	18.43%
Profit (Net Income) Margin	17.32%	13.85%	20.47%	21.85%	21.03%	18.50%	24.04%	13.37%	12.94%	11.56%	17.52%
Tax Burden Percent	92.73%	89.60%	92.06%	92.46%	86.95%	95.21%	89.45%	85.33%	88.26%	88.69%	87.75%
Interest Burden Percent	117.25%	123.59%	116.91%	117.42%	116.56%	121.19%	114.85%	127.74%	140.95%	115.48%	108.29%
Effective Tax Rate	7.27%	10.40%	7.94%	7.54%	13.05%	4.79%	10.55%	14.67%	11.74%	11.31%	12.25%
Return on Invested Capital (ROIC)	12.43%	9.03%	13.97%	15.98%	16.31%	14.32%	20.58%	10.64%	9.30%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	11.69%	8.23%	12.83%	14.86%	15.38%	13.24%	19.63%	9.88%	8.50%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-4.23%	-3.08%	-4.99%	-5.94%	-6.34%	-5.60%	-8.44%	-4.38%	-4.00%	0.00%	0.00%
Return on Equity (ROE)	8.19%	5.96%	8.98%	10.03%	9.96%	8.72%	12.14%	6.26%	5.29%	0.00%	0.00%
Cash Return on Invested Capital (CROIC)	8.90%	11.11%	11.50%	13.64%	16.49%	12.91%	15.16%	13.99%	16.96%	-32.12%	-34.40%
Operating Return on Assets (OROA)	7.42%	5.51%	8.56%	9.44%	9.94%	7.86%	11.79%	6.13%	4.89%	0.00%	0.00%
Return on Assets (ROA)	8.07%	6.10%	9.22%	10.25%	10.07%	9.07%	12.11%	6.69%	6.09%	0.00%	0.00%
Return on Common Equity (ROCE)	8.19%	5.96%	8.98%	10.03%	9.96%	8.72%	12.14%	6.26%	5.29%	0.00%	0.00%
Return on Equity Simple (ROE_SIMPLE)	9.26%	0.00%	7.80%	9.06%	9.62%	0.00%	11.40%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	32	25	39	45	46	40	56	28	21	30	56
NOPAT Margin	15.22%	11.56%	17.19%	18.63%	18.30%	15.32%	21.18%	10.85%	9.58%	10.18%	16.25%
Net Nonoperating Expense Percent (NNEP)	0.74%	0.81%	1.13%	1.12%	0.93%	1.08%	0.96%	0.76%	0.80%	0.54%	0.66%
Return On Investment Capital (ROIC_SIMPLE)	-	1.46%	-	-	-	2.10%	2.94%	1.40%	1.04%	1.39%	1.64%
Cost of Revenue to Revenue	48.43%	50.67%	48.31%	47.08%	45.93%	49.83%	46.28%	54.30%	51.17%	51.64%	47.69%
SG&A Expenses to Revenue	8.75%	12.34%	7.67%	8.37%	8.91%	9.68%	8.97%	9.86%	11.38%	10.76%	9.98%
R&D to Revenue	12.61%	10.98%	11.60%	11.16%	11.21%	13.22%	10.51%	13.92%	14.89%	12.02%	11.33%
Operating Expenses to Revenue	35.16%	36.43%	33.01%	32.77%	33.03%	34.08%	30.04%	32.99%	37.98%	36.88%	33.79%
Earnings before Interest and Taxes (EBIT)	33	27	44	49	52	42	62	31	23	33	63
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	50	44	60	65	69	54	74	44	35	58	90
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.69	4.32	4.99	5.91	5.59	4.38	3.13	2.46	3.12	4.78	9.79
Price to Tangible Book Value (P/TBV)	5.22	5.99	6.78	7.87	7.29	5.74	4.09	3.17	3.98	8.42	18.45
Price to Revenue (P/Rev)	7.36	9.20	10.51	12.06	11.29	8.54	5.87	4.66	6.24	0.00	0.00
Price to Earnings (P/E)	39.84	61.94	63.97	65.18	58.07	41.80	27.47	24.18	35.72	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	2.51%	1.61%	1.56%	1.53%	1.72%	2.39%	3.64%	4.14%	2.80%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	5.28	6.55	7.83	9.60	9.33	7.06	4.83	3.69	5.17	6.45	12.18
Enterprise Value to Revenue (EV/Rev)	6.62	8.34	9.63	11.18	10.38	7.67	5.04	3.80	5.26	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	26.21	37.93	42.00	45.69	40.94	30.40	19.52	16.08	24.82	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	38.03	60.65	64.15	65.71	56.86	40.53	25.09	20.93	33.24	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	39.49	64.17	68.34	71.00	62.70	44.27	27.42	23.08	36.26	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	35.20	39.58	45.50	47.18	38.92	30.84	18.41	14.42	18.21	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	60.72	58.68	68.06	70.27	56.10	55.57	32.29	26.62	30.06	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.77
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.77
Financial Leverage	-0.36	-0.37	-0.39	-0.40	-0.41	-0.42	-0.43	-0.44	-0.47	-0.37	-0.34
Leverage Ratio	1.12	1.11	1.10	1.10	1.09	1.10	1.10	1.09	1.09	1.11	1.50
Compound Leverage Factor	1.31	1.37	1.29	1.29	1.27	1.33	1.26	1.40	1.54	1.29	1.63
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	43.36%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	43.36%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	56.64%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	24.16	27.54	32.65	39.04	39.30	28.16	20.23	18.13	22.05	24.20	7.50
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	9.00	8.69	9.06	9.33	10.07	8.69	8.42	9.59	9.49	6.15	9.73
Quick Ratio	6.18	6.26	6.62	6.90	7.66	6.82	6.55	7.58	7.64	4.48	8.17
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-18	35	40	47	65	5.60	28	4.83	51	-379	-388
Operating Cash Flow to CapEx	374.42%	2,500.45%	819.08%	532.92%	835.47%	1,210.53%	1,117.21%	420.73%	6,047.57%	734.23%	1,681.90%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.47	0.44	0.45	0.47	0.48	0.49	0.50	0.50	0.47	0.00	0.00
Accounts Receivable Turnover	3.82	3.49	3.83	4.22	4.07	3.69	3.92	3.96	3.90	0.00	0.00
Inventory Turnover	1.23	1.21	1.23	1.30	1.38	1.54	1.56	1.72	1.77	0.00	0.00
Fixed Asset Turnover	9.02	8.34	8.27	8.33	8.40	8.68	8.76	8.34	8.05	0.00	0.00
Accounts Payable Turnover	7.39	7.58	7.52	8.63	9.76	8.90	8.71	11.40	9.95	0.00	0.00
Days Sales Outstanding (DSO)	95.52	104.68	95.29	86.59	89.72	98.84	93.19	92.13	93.57	0.00	0.00
Days Inventory Outstanding (DIO)	297.78	300.80	295.85	281.28	264.57	237.69	234.20	211.75	206.34	0.00	0.00
Days Payable Outstanding (DPO)	49.37	48.16	48.55	42.28	37.38	41.03	41.89	32.03	36.68	0.00	0.00
Cash Conversion Cycle (CCC)	343.93	357.32	342.59	325.58	316.91	295.49	285.51	271.85	263.23	0.00	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,066	1,039	1,041	1,046	1,048	1,074	1,069	1,068	1,018	1,478	1,512
Invested Capital Turnover	0.82	0.78	0.81	0.86	0.89	0.93	0.97	0.98	0.97	0.00	0.00
Increase / (Decrease) in Invested Capital	50	-9.92	-0.49	-1.47	-18	35	28	23	-30	409	444
Enterprise Value (EV)	5,627	6,807	8,147	10,033	9,780	7,577	5,164	3,938	5,268	9,538	18,415
Market Capitalization	6,257	7,504	8,888	10,819	10,636	8,429	6,014	4,833	6,252	10,192	18,825
Book Value per Share	$34.57	$35.38	$36.19	$37.17	$38.55	$38.99	$38.96	$40.17	$40.86	$42.90	$38.65
Tangible Book Value per Share	$24.45	$25.54	$26.64	$27.90	$29.56	$29.73	$29.85	$31.15	$32.04	$24.35	$20.52
Total Capital	1,696	1,737	1,782	1,832	1,904	1,926	1,920	1,963	2,002	2,132	3,394
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1,472
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1,472
Net Debt	-630	-698	-741	-786	-855	-852	-851	-895	-984	-654	-410
Capital Expenditures (CapEx)	7.65	2.46	6.98	12	8.05	4.63	8.23	14	1.38	3.59	3.66
Debt-free, Cash-free Net Working Capital (DFCFNWC)	456	438	445	451	458	455	444	444	398	451	488
Debt-free Net Working Capital (DFNWC)	1,085	1,136	1,186	1,237	1,313	1,307	1,295	1,339	1,382	1,105	2,370
Net Working Capital (NWC)	1,085	1,136	1,186	1,237	1,313	1,307	1,295	1,339	1,382	1,105	2,370
Net Nonoperating Expense (NNE)	-4.35	-5.01	-7.51	-7.80	-6.91	-8.39	-7.62	-6.39	-7.32	-4.02	-4.34
Net Nonoperating Obligations (NNO)	-630	-698	-741	-786	-855	-852	-851	-895	-984	-654	-410
Total Depreciation and Amortization (D&A)	17	17	17	17	17	12	11	13	12	25	27
Debt-free, Cash-free Net Working Capital to Revenue	53.60%	53.65%	52.61%	50.24%	48.59%	46.09%	43.33%	42.81%	39.72%	0.00%	0.00%
Debt-free Net Working Capital to Revenue	127.66%	139.18%	140.24%	137.85%	139.37%	132.42%	126.31%	129.17%	137.88%	0.00%	0.00%
Net Working Capital to Revenue	127.66%	139.18%	140.24%	137.85%	139.37%	132.42%	126.31%	129.17%	137.88%	0.00%	0.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.73	$0.61	$0.95	$1.07	$1.07	$1.00	$1.30	$0.69	$0.58	$0.68	$1.22
Adjusted Weighted Average Basic Shares Outstanding	49.04M	48.97M	49.23M	49.34M	49.43M	49.34M	49.18M	48.93M	49.02M	49.74M	49.41M
Adjusted Diluted Earnings per Share	$0.73	$0.61	$0.94	$1.07	$1.07	$0.98	$1.30	$0.69	$0.57	$0.67	$1.21
Adjusted Weighted Average Diluted Shares Outstanding	49.40M	49.32M	49.64M	49.67M	49.69M	49.66M	49.41M	49.02M	49.11M	50.00M	49.68M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	49.08M	49.13M	49.28M	49.38M	49.39M	49.27M	48.87M	49.00M	49.01M	49.74M	49.07M
Normalized Net Operating Profit after Tax (NOPAT)	32	25	39	45	46	40	56	28	21	30	56
Normalized NOPAT Margin	15.22%	11.56%	17.19%	18.63%	18.30%	15.32%	21.18%	10.85%	9.58%	10.18%	16.25%
Pre Tax Income Margin	18.68%	15.46%	22.24%	23.63%	24.19%	19.43%	26.88%	15.67%	14.66%	13.03%	19.96%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	36.24%	2.64%	0.00%	0.00%	0.00%	12.43%	45.72%	50.07%	57.18%	0.00%	0.00%

Financials Breakdown Chart

Key Financial Trends

Onto Innovation’s latest results show strong revenue growth but weaker profitability and cash generation. Q1 2026 revenue increased to $291.9 million from $266.6 million in Q1 2025 and $218.9 million in Q4 2023. However, net income fell to $33.8 million from $64.1 million a year earlier, while diluted EPS declined to $0.67 from $1.30. The company’s gross margin also narrowed to approximately 50.1% from 53.7% in Q1 2025, and its operating margin fell to roughly 11.5% from 23.7%.

The longer-term revenue trend remains favorable. Quarterly revenue rose from $199.2 million in Q1 2023 to $291.9 million in Q1 2026, although earnings have been uneven. Net income increased from $29.1 million in Q1 2023 to $64.1 million in Q1 2025 before retreating to $33.8 million in the latest quarter. Higher operating expenses, including $19.7 million of amortization in Q1 2026 versus $8.4 million in Q1 2025, were a significant factor in the margin decline. Goodwill and intangible assets also increased sharply, reaching $921.9 million combined in Q1 2026 from $432.2 million in Q3 2025, which appears consistent with the impact of an acquisition or acquisition-related accounting.

Onto continues to have a strong balance sheet, but liquidity shifted during the quarter. Cash and short-term investments totaled approximately $654.2 million at March 31, 2026, down from nearly $983.9 million in Q3 2025. The company generated $26.3 million of operating cash flow, compared with $92.0 million in Q1 2025, as changes in operating assets and liabilities consumed $41.6 million. Investing cash flow was negative $112.6 million, primarily because the company purchased $179.5 million of investments. Total liabilities remained modest at $264.2 million, and no traditional debt balance was reported in the supplied statements.

Revenue growth: Q1 2026 revenue of $291.9 million was up approximately 9.5% year over year and 33.8% from Q3 2025.
Strong balance-sheet liquidity: Cash and short-term investments totaled about $654.2 million, while total liabilities were only $264.2 million.
Significant shareholder equity: Total equity increased to $2.13 billion in Q1 2026 from $1.92 billion in Q1 2024, supporting financial flexibility.
Consistent profitability: Onto remained profitable in every supplied quarter, with positive operating and net income despite recent margin pressure.
Limited capital-return pressure in the latest quarter: The company reported no common-stock repurchases in Q1 2026, preserving cash while profitability and working capital were under pressure.
Investment portfolio activity: Onto frequently purchased and sold short-term investments, creating significant quarter-to-quarter swings in investing cash flow without necessarily reflecting changes in core operations.
Acquisition-related balance-sheet changes: The sharp increase in goodwill and intangible assets may expand the company’s product capabilities, but the long-term payoff will depend on successful integration and earnings growth.
Profitability deterioration: Q1 2026 net income declined approximately 47% year over year, and diluted EPS fell from $1.30 to $0.67.
Lower operating cash conversion: Operating cash flow dropped to $26.3 million from $92.0 million in Q1 2025, with working-capital changes producing a $41.6 million cash use.
Higher amortization and weaker margins: Amortization more than doubled from Q1 2025, while the operating margin contracted to about 11.5%, increasing the risk that acquisition-related costs will weigh on reported earnings.

08/22/26 11:08 PM ETAI Generated. May Contain Errors.

Onto Innovation Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Onto Innovation's fiscal year ends in January. Their fiscal year 2026 ended on January 3, 2026.

Onto Innovation's net income appears to be on an upward trend, with a most recent value of $136.76 million in 2024, falling from -$31.12 million in 2014. The previous period was $121.16 million in 2023. Check out Onto Innovation's forecast to explore projected trends and price targets.

Onto Innovation's total operating income in 2024 was $132.93 million, based on the following breakdown:

Total Gross Profit: $499.77 million
Total Operating Expenses: $366.84 million

Over the last 10 years, Onto Innovation's total revenue changed from $166.44 million in 2014 to $1.01 billion in 2024, a change of 504.0%.

Onto Innovation's total liabilities were at $267.09 million at the end of 2025, a 39.7% increase from 2024, and a 454.0% increase since 2015.

In the past 10 years, Onto Innovation's cash and equivalents has ranged from $34.90 million in 2017 to $346.12 million in 2025, and is currently $346.12 million as of their latest financial filing in 2025.

Over the last 10 years, Onto Innovation's book value per share changed from 7.43 in 2014 to 38.99 in 2024, a change of 424.7%.

Related Companies

Financial statements for NYSE:ONTO last updated on 8/6/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Onto Innovation (ONTO) Financials

Financials Breakdown Chart

Key Financial Trends

Onto Innovation Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Onto Innovation (ONTO) Financials

Annual Income Statements for Onto Innovation

Quarterly Income Statements for Onto Innovation

Annual Cash Flow Statements for Onto Innovation

Quarterly Cash Flow Statements for Onto Innovation

Annual Balance Sheets for Onto Innovation

Quarterly Balance Sheets for Onto Innovation

Annual Metrics And Ratios for Onto Innovation

Quarterly Metrics And Ratios for Onto Innovation

Financials Breakdown Chart

Key Financial Trends

Onto Innovation Financials - Frequently Asked Questions

When does Onto Innovation's financial year end?

How has Onto Innovation's net income changed over the last 10 years?

What is Onto Innovation's operating income?

How has Onto Innovation's revenue changed over the last 10 years?

How much debt does Onto Innovation have?

How much cash does Onto Innovation have?

How has Onto Innovation's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools